ShanXi C&Y Pharmaceutical Group Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 394.615 million compared to CNY 557.987 million a year ago. Operating loss was CNY 84.609 million compared to operating Income of CNY 18.499 million a year ago. Net loss was CNY 75.229 million compared to net income of CNY 42.131 million a year ago. Basic loss per share from continuing operations was CNY 0.3611 compared to basic earnings per share from continuing operations of CNY 0.2023 a year ago.